Vaccines Bioprocess Development and Commercialisation (MBI® Training, Bioprocess Industries)

Course

In London

Price on request

Description

  • Type

    Course

  • Level

    Intermediate

  • Location

    London

  • Class hours

    20h

  • Duration

    3 Days

  • Start date

    Different dates available

This three-day workshop will explore the critical issues at each stage of vaccine development.
You'll hear from international experts about the research, operational and regulatory challenges of the vaccine market.
The course is for research scientists, programme managers, process engineers and policy makers.
This workshop is being run by UCL in collaboration with Massachusetts Institute of Technology (MIT). It's part of the Modular Training for the Bioprocess Industries programme (MBI®), run by the Department of Biochemical Engineering at UCL.

Facilities

Location

Start date

London
See map
Gower Street, WC1E 6BT

Start date

Different dates availableEnrolment now open

About this course

By attending an MBI® course, you'll:
benefit from knowledge transfer and upskilling in core bioprocessing fundamentals and trends in industry
gain a deeper understanding of process options and engineering constraints
acquire the tools to optimise process performance and economics
learn about the latest technical and regulatory developments
have access to cutting edge research methodologies
network with sector leaders and subject matter experts
increase your flexibility, motivation, creativity and professional status

The course is for research scientists, programme managers, process engineers and policy makers.
It's suitable for:
those new to the vaccines sector (recent graduates/research scientists)
specialised vaccines staff who want to broaden their knowledge of vaccine technologies and platforms
project managers, funders and policy-makers wanting to gain an understanding of vaccines

Questions & Answers

Add your question

Our advisors and other users will be able to reply to you

Who would you like to address this question to?

Fill in your details to get a reply

We will only publish your name and question

Reviews

This centre's achievements

2018

All courses are up to date

The average rating is higher than 3.7

More than 50 reviews in the last 12 months

This centre has featured on Emagister for 14 years

Subjects

  • Bioprocess
  • Bioprocess Development
  • Commercialisation
  • HIV vaccine
  • Viral vaccines
  • Human viral vaccines
  • Project Management
  • Legacy vaccines
  • Manufacturing
  • Clinical trial design

Course programme

Teaching is in small classes, with an emphasis on interactive problem solving and case studies.

Each day will cover the following topics:

Day 1
  • Challenges toward developing an HIV vaccine
  • Development and case studies of recombinant vaccines
  • Viral vaccines: manufacturing and development challenges
  • Adjuvants and formulation
Day 2
  • The quality control of human viral vaccines
  • Testing and control of adventitious agents
  • Conjugate vaccines: Overview and challenges
  • Analytical tools for 21st century vaccines
  • Case study: vaccine commercialisation and project management - live influenza virus vaccine
  • Bridging legacy vaccines
Day 3
  • Integrated and automated manufacturing
  • New therapies based on the controlled modulation of the immune system
  • Clinical trial design
  • Vision for improved process development

Vaccines Bioprocess Development and Commercialisation (MBI® Training, Bioprocess Industries)

Price on request